{"nct_id":"NCT01256073","title":"A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia","status":"COMPLETED","status_verified_date":"2014-02","start_date":"2007-02","start_date_type":null,"primary_completion_date":"2013-07","primary_completion_date_type":"ACTUAL","completion_date":"2013-09","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["IPHA"]}